Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

China cracks down on spurious, illegal, pricey vaccines

Published 2021-02-15, 01:38 a/m

SHANGHAI (Reuters) - China is cracking down on vaccine-related crimes, making dozens of arrests over the production and distribution of fake coronavirus vaccines, price gouging and illegal inoculations, the official Xinhua news agency said on Monday.

Authorities had arrested 70 suspects by Wednesday, in 21 vaccine-related cases, it added, many of which surfaced during the initial phases of rollout.

One group of suspects made a profit of about 18 million yuan ($2.8 million) by packaging saline solution or mineral water in 58,000 doses of spurious vaccines, Xinhua said, identifying its leader, arrested last Christmas Day, only by the surname Kong.

In other cases, fake vaccines were sold at high prices, included in emergency inoculation schemes at hospitals, or smuggled abroad, it added.

China's Supreme People's Procuratorate urged regional agencies to cooperate with police in swift and unwavering action to curb such activities, the agency said.

China, which had given 40.52 million doses of vaccine to key groups of people by Tuesday, has largely managed to bring the pandemic under control with strict lockdown, testing and tracing measures.

($1=6.4542 Chinese yuan renminbi)

(Interactive graphic tracking global spread of coronavirus: https://graphics.reuters.com/world-coronavirus-tracker-and-maps)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.